The evolution of genome-scale models of cancer metabolism

Frontiers in Physiology

Volumn 4 SEP, Issue , 2013, Pages

  Lewis, Nathan E ^a   Abdel Haleem, Alyaa M ^b  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b The American University in Cairo   (Egypt)

Author keywords

Cancer; Constraint based modeling; Data analysis; Metabolism; Modeling and simulation; Omics; Systems biology; Warburg effect

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BILIRUBIN; BILIVERDIN; ICOSANOID; ISOPRENOID; PENTOSE PHOSPHATE; POLYAMINE;

ALGORITHM; BIOCHEMISTRY; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CITRIC ACID CYCLE; ENZYME METABOLISM; EPIGENETICS; GENOME; GENOME SCALE MODEL; GLYCOLYSIS; HUMAN GENOME; INTEGRATIVE METABOLIC ANALYSIS TOOL; INTIGRATIVE NETWORK INFERENCE FOR TISSUES; KIDNEY CANCER; LEIOMYOMATOSIS; METABOLIC CONTEXT SPECIFICITY BY DETERMINISTIC REACTION EVALUATION; METABOLIC PHENOTYPE ANALYSIS; METABOLISM; METASTASIS; MOLECULAR MODEL; NEOPLASM; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PROTEIN PROCESSING; SHORT SURVEY; TUMOR GROWTH;

EID: 84884565153     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00237     Document Type: Short Survey

References (58)

1. Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N., Nookaew, I., and Nielsen, J. (2012). Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput. Biol. 8, e1002518. doi: 10.1371/journal.pcbi.1002518
2. Beltrao, P., Albanése, V., Kenner, L. R., Swaney, D. L., Burlingame, A., Villén, J., et al. (2012). Systematic functional prioritization of protein posttranslational modifications. Cell 150, 413-425. doi: 10.1016/j.cell.2012.05.036
3. Blazier, A. S., and Papin, J. A. (2012). Integration of expression data in genome-scale metabolic network reconstructions. Front. Physiol. 3, 299. doi: 10.3389/fphys.2012.00299
4. Bordbar, A., Feist, A. M., Usaite-Black, R., Woodcock, J., Palsson, B. O., and Famili, I. (2011). A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst. biol. 5, 180. doi: 10.1186/1752-0509-5-180
5. Cairns, R. A., Harris, I. S., and Mak, T. W. (2011). Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95.
6. Cohen, A. A., Geva-Zatorsky, N., Eden, E., Frenkel-Morgenstern, M., Issaeva, I., Sigal, A., et al. (2008). Dynamic proteomics of individual cancer cells in response to a drug. Science 322, 1511-1516. doi: 10.1126/science.1160165
7. Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., et al. (2007). Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U.S.A. 104, 1777-1782. doi: 10.1073/pnas.0610772104
8. Dulbecco, R. (1986). A turning point in cancer research, sequencing the human genome. Science 231, 1055-1056. doi: 10.1126/science.3945817
9. Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., and Shlomi, T. (2011). Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 7, 501.
10. Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., et al. (2011). COSMIC, mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res. 39, D945-D950. doi: 10.1093/nar/gkq929
11. Frezza, C., Pollard, P. J., and Gottlieb, E. (2011a). Inborn and acquired metabolic defects in cancer. J. Mol. Med. 89, 213-220.
12. Frezza, C., Zheng, L., Folger, O., Rajagopalan, K. N., MacKenzie, E. D., Jerby, L., et al. (2011b). Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477, 225-228.
13. Giatromanolaki, A., Koukourakis, M. I., Koutsopoulos, A., Mendrinos, S., and Sivridis, E. (2012). The metabolic interactions between tumor cells and tumorassociated stroma (TAS) in prostatic cancer. Cancer Biol. Ther. 13, 1284-1289. doi: 10.4161/cbt.21785
14. Goldstein, I., Yizhak, K., Madar, S., Goldfinger, N., Ruppin, E., and Rotter, V. (2013). p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab. 1, 9. doi: 10.1186/2049-3002-1-9
15. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer, the next generation. Cell 144, 646-674. doi: 10.1016/j.cell.2011.02.013
16. Hernández Patiño, C. E., Jaime-Muñoz, G., and Resendis-Antonio, O. (2012). Systems biology of cancer, moving toward the integrative study of the metabolic alterations in cancer cells. Front. Physiol. 3, 481. doi: 10.3389/fphys.2012.00481
17. Hudson, T. J., Anderson, W., Artez, A., Barker, A. D., Bell, C., Bernabé, R. R., et al. (2010). International network of cancer genome projects. Nature 464, 993-998. doi: 10.1038/nature08987
18. Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N., Nookaew, I., and Nielsen, J. (2012). Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput. Biol. 8, e1002518. doi: 10.1371/journal.pcbi.1002518
19. Beltrao, P., Albanése, V., Kenner, L. R., Swaney, D. L., Burlingame, A., Villén, J., et al. (2012). Systematic functional prioritization of protein posttranslational modifications. Cell 150, 413-425. doi: 10.1016/j.cell.2012.05.036
20. Blazier, A. S., and Papin, J. A. (2012). Integration of expression data in genome-scale metabolic network reconstructions. Front. Physiol. 3, 299. doi: 10.3389/fphys.2012.00299
21. Bordbar, A., Feist, A. M., Usaite-Black, R., Woodcock, J., Palsson, B. O., and Famili, I. (2011). A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst. biol. 5, 180. doi: 10.1186/1752-0509-5-180
22. Cairns, R. A., Harris, I. S., and Mak, T. W. (2011). Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95.
23. Cohen, A. A., Geva-Zatorsky, N., Eden, E., Frenkel-Morgenstern, M., Issaeva, I., Sigal, A., et al. (2008). Dynamic proteomics of individual cancer cells in response to a drug. Science 322, 1511-1516. doi: 10.1126/science.1160165
24. Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., et al. (2007). Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U.S.A. 104, 1777-1782. doi: 10.1073/pnas.0610772104
25. Dulbecco, R. (1986). A turning point in cancer research, sequencing the human genome. Science 231, 1055-1056. doi: 10.1126/science.3945817
26. Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., and Shlomi, T. (2011). Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 7, 501.
27. Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., et al. (2011). COSMIC, mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res. 39, D945-D950. doi: 10.1093/nar/gkq929
28. Frezza, C., Pollard, P. J., and Gottlieb, E. (2011a). Inborn and acquired metabolic defects in cancer. J. Mol. Med. 89, 213-220.
29. Frezza, C., Zheng, L., Folger, O., Rajagopalan, K. N., MacKenzie, E. D., Jerby, L., et al. (2011b). Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477, 225-228.
30. Giatromanolaki, A., Koukourakis, M. I., Koutsopoulos, A., Mendrinos, S., and Sivridis, E. (2012). The metabolic interactions between tumor cells and tumorassociated stroma (TAS) in prostatic cancer. Cancer Biol. Ther. 13, 1284-1289. doi: 10.4161/cbt.21785
31. Goldstein, I., Yizhak, K., Madar, S., Goldfinger, N., Ruppin, E., and Rotter, V. (2013). p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab. 1, 9. doi: 10.1186/2049-3002-1-9
32. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer, the next generation. Cell 144, 646-674. doi: 10.1016/j.cell.2011.02.013
33. Hernández Patiño, C. E., Jaime-Muñoz, G., and Resendis-Antonio, O. (2012). Systems biology of cancer, moving toward the integrative study of the metabolic alterations in cancer cells. Front. Physiol. 3, 481. doi: 10.3389/fphys.2012.00481
34. Hudson, T. J., Anderson, W., Artez, A., Barker, A. D., Bell, C., Bernabé, R. R., et al. (2010). International network of cancer genome projects. Nature 464, 993-998. doi: 10.1038/nature08987
35. Price, N. D., Reed, J. L., and Palsson, B. O. (2004). Genome-scale models of microbial cells, evaluating the consequences of constraints. Nat. Rev. Microbiol. 2, 886-897. doi: 10.1038/nrmicro1023
36. Resendis-Antonio, O., Checa, A., and Encarnación, S. (2010). Modeling core metabolism in cancer cells, surveying the topology underlying the warburg effect. PLoS ONE 5, e12383. doi: 10.1371/journal.pone.0012383
37. Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., et al. (2013). Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science 339, 1320-1323. doi: 10.1126/science.1228771
38. Sasaki, M., Knobbe, C. B., Munger, J. C., Lind, E. F., Brenner, D., Brüstle, A., et al. (2012). IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488, 656-659. doi: 10.1038/nature11323
39. Schuster-Böckler, B., and Lehner, B. (2012). Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488, 504-507. doi: 10.1038/nature11273
40. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732. doi: 10.1038/nrc1187
41. Sharma, A. K., and König, R. (2013). Metabolic network modeling approaches for investigating the "hungry cancer." Semin. Cancer Biol. 23, 227-234. doi: 10.1016/j.semcancer.2013.05.001
42. Shlomi, T., Benyamini, T., Gottlieb, E., Sharan, R., and Ruppin, E. (2011). Genome-Scale metabolic modeling elucidates the role of proliferative adaptation in causing the warburg effect. PLoS Comput. Biol. 7, e1002018. doi: 10.1371/journal.pcbi.1002018
43. Shlomi, T., Cabili, M. N., Herrgård, M. J., Palsson, B. O., and Ruppin, E. (2008). Network-based prediction of human tissue-specific metabolism. Nat. Biotechnol. 26, 1003-1010. doi: 10.1038/nbt.1487
44. Simeonidis, E., Chandrasekaran, S., and Price, N. D. (2013). A guide to integrating transcriptional regulatory and metabolic networks using PROM (probabilistic regulation of metabolism). Methods Mol. Biol. 985, 103-112. doi: 10.1007/978-1-62703-299-5_6
45. Solit, D. B., and Mellinghoff, I. K. (2010). Tracing cancer networks with phosphoproteomics. Nat. Biotechnol. 28, 1028-1029. doi: 10.1038/nbt1010-1028
46. Thiele, I., Fleming, R. M. T., Bordbar, A., Schellenberger, J., and Palsson, B. O. (2010). Functional characterization of alternate optimal solutions of Escherichia coli's transcriptional and translational machinery. Biophys. J. 98, 2072-2081. doi: 10.1016/j.bpj.2010.01.060
47. Thiele, I., Fleming, R. M. T., Que, R., Bordbar, A., Diep, D., and Palsson, B. O. (2012). Multiscale modeling of metabolism and macromolecular synthesis in E. coli and its application to the evolution of codon usage. PLoS ONE 7, e45635. doi: 10.1371/journal.pone.0045635
48. Thiele, I., Swainston, N., Fleming, R. M. T., Hoppe, A., Sahoo, S., Aurich, M. K., et al. (2013). A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419-425. doi: 10.1038/nbt.2488
49. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., et al. (2010). Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250. doi: 10.1038/nbt1210-1248
50. Vazquez, A., and Oltvai, Z. N. (2011). Molecular crowding defines a common origin for the Warburg effect in proliferating cells and the lactate threshold in muscle physiology. PLoS ONE 6, e19538. doi: 10.1371/journal.pone.0019538
51. Vazquez, A., Liu, J., Zhou, Y., and Oltvai, Z. N. (2010). Catabolic efficiency of aerobic glycolysis, the Warburg effect revisited. BMC Syst. Biol. 4, 58. doi: 10.1186/1752-0509-4-58
52. Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., and Kinzler, K. W. (2013). Cancer genome landscapes. Science 339, 1546-1558. doi: 10.1126/science.1235122
53. Wang, Y., Eddy, J. A., and Price, N. D. (2012). Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst. Biol. 6, 153. doi: 10.1186/1752-0509-6-153
54. Wellen, K. E., Lu, C., Mancuso, A., Lemons, J. M. S., Ryczko, M., Dennis, J. W., et al. (2010). The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev. 24, 2784-2799. doi: 10.1101/gad.1985910
55. Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., et al. (2013). HMDB 3.0-the human metabolome database in 2013. Nucleic Acids Res. 41, D801-D807.
56. Yates, L. R., and Campbell, P. J. (2012). Evolution of the cancer genome. Nat. Rev. Genet. 13, 795-806. doi: 10.1038/nrg3317
57. Ye, Y. N., Wu, W. K. K., Shin, V. Y., and Cho, C. H. (2005). A mechanistic study of colon cancer growth promoted by cigarette smoke extract. Eur. J. Pharmacol. 519, 52-57. doi: 10.1016/j.ejphar.2005.07.009
58. Zomorrodi, A. R., and Maranas, C. D. (2012). OptCom, a multi-level optimization framework for the metabolic modeling and analysis of microbial communities. PLoS Comput. Biol. 8, e1002363. doi: 10.1371/journal.pcbi.1002363